Hexagon Nutrition IPO covers 1.65x on day one as retail piles in at 2.42x
The ₹139-crore issue from the maker of Pentasure and Pediagold drew 2.03x demand from NIIs alongside the retail surge, with anchors already locking in ₹41.66 crore. Grey market premium of ₹6.5 on the ₹42-45 band points to a modest listing pop on June 12.
What happened
Hexagon Nutrition's ₹139-crore IPO subscribed 1.65x on day one, led by retail (2.42x) and NII (2.03x). The clinical nutrition company behind Pentasure and
Key facts
- ₹139 crore issue size
- 1.65x subscribed day 1
- retail 2.42x
- NII 2.03x
- price band ₹42-45
- anchor ₹41.66 crore
- GMP ₹6.5
- 75 countries
Why this matters
Hexagon's successful ₹139-crore raise at this valuation sets a benchmark for clinical nutrition M&A multiples in India, signaling capital availability for niche specialty nutrition assets that larger FMCG players may target.